International Cardio-Oncology Society
@ICOSociety
Clinicians and researchers committed to eliminating cardiac disease as a barrier to effective cancer therapies Follow/RT not endorsement or medical advice
New in #JACCCardioOnc: After hematopoietic stem cell transplant #HSCT, ~1 in 4 patients developed #POTS, and it was linked to: 🔹Exaggerated norepinephrine rise on standing 🔹Higher adrenergic receptor-modulating autoantibody activity 📖: jacc.org/doi/abs/10.101… @AbbateAntonio
@RajaZaghlol, a fantastic @WashUCardiology fellow, led this impactful study on afib in stem cell tx patients. Patients with afib were 3-4x more likely to die in the hospital, and 50% more likely to die in 90 days after discharge. Congrats! @ICOSociety #cardioonc
🚨Recently published in #CardioOncology Atrial fibrillation or flutter in patients undergoing stem cell transplantation, in-hospital and post-discharge outcomes in a large nationwide sample across the United States🔍 #OpenAccess #CardiovascularHealth 👉doi.org/pvw8
Honoured to help celebrate cancer survivorship at the Wilmot Cancer Institute Survivorship night at the Rochester Red Wings baseball game! @ASCOPost @WilmotCancer @PlutaCancerFdn @ICOSociety
🚫 MYTH: “Your treatment is over. Go live your life.” ✅ FACT: Some cancer treatments require long-term monitoring of heart health. What other cardio-oncology myths have you heard? #MythVsFact #CardioOncology #CancerCareAwareness #cardioonc
💫 Next #CardioOnc webinar | 'Integrating Psychological Support into Pediatric Cardio-Oncology Care: Enhancing Outcomes for Patients and Families' 👉 ow.ly/6Q9n50Wtqg3 🗓️ Thursday 24 July, 14:00 BST | 09:00 EDT Chairs Dr Dan Lenihan and Dr Joe Carver will be joined by…
As technology continues to evolve, our ability to produce better outcomes advances. At #GCOS25🇿🇦, @DrRowIlling (🇺🇸 US), Chief Medical Officer at @awscloud will discuss how advances in AI, the Cloud, and more will drive the future of healthcare. Join us: tinyurl.com/72dnxrsp
1/6📢 Excited to share our new publication in @BioMedCentral (BMC Cardio-Oncology): We explored #CardioMEMS 📡 for heart failure management in cancer patients—a group often overlooked in trials. Grateful to @cezar_ciliescu for his mentorship.📖 rdcu.be/ewUQd #CardioOnc
Too much waste. Too much waiting. Too much #scanxiety. Happy to share that we received @CIHR_IRSC funding for the JUSTIFY RCT (NCT06930521), which will test a novel approach to reduce mandatory routine heart imaging during HER2+ #breastcancer treatment. #CardioOncology
📢Calling all prospective Centers of Excellence📢 This year's application deadline is officially one month from now. Submit your application by August 16th to distinguish your institution's expertise. Submit here: tinyurl.com/2s3mkkf5
🔴 NEW Cardio-oncology webinar – Join this week's session on enhancing cardioprotection utilising myocardial strain: ow.ly/iH6m50WpKaC Drs Joe Carver, Dan Lenihan and Teresa López Fernández discuss cardioprotection strategies in cardio-oncology. #CardioOnc #Cardiology…
We're here to settle the debate - does traditional #radiation therapy still have a place in modern #cancer treatment? Alex Lyon, MD (🇬🇧 UK), @sdent_cardioonc (🇺🇸 US), and @md_arianemacedo (🇧🇷 BRA) provide perspectives at #GCOS25. Join us in Cape Town🇿🇦: tinyurl.com/6we5s88y
Excited to share that I’ll be joining the Global Cardio-Oncology Summit 25 @cososa_society inCape Town, alongside the pioneers Dr. Alex Lyon and Dr @sdent_cardioonc. Global dialogue led by @ICOSociety. Let’s keep building bridges between 🫀 and cancer care, grounded in science.
🔦MEMBER SPOTLIGHT🔦 Kasey Leger, MD leads the Leukemia & Lymphoma program at @seattlechildren and teaches at @uwsomwwami. Dr Leger's research focuses on protecting the hearts of children who have undergone cancer treatment. Learn more about Dr Leger: tinyurl.com/3f5fz9h6
👋 Have you registered? | Cardio-oncology experts explore how cardiac MRI can help detect myocardial injury and cardiotoxicity in patients undergoing cancer-related chemotherapy. PROGRAMME: • Diagnostic value, clinical integration and imaging techniques • One-hour programme…
Using Danish population-based registries, #JACCCardioOnc study found elevated long-term #CVrisk in cancer survivors post systemic therapy 🔹HF/cardiomyopathy (HR 1.08) 🔹#VTE (HR 1.50) 🔹#Myocarditis/pericarditis (HR 1.30) 🔹Kidney failure (HR 1.17) 🔗 jacc.org/doi/10.1016/j.…
Proper fitness is a vital component in preventing #cardiotoxicity in #cancer survivors and promoting healthy living. Join @erin_howden (🇦🇺 AUS) at #GCOS25 for an exciting session on how to integrate #CORE into treatment. Join Us In Cape Town 🇿🇦: tinyurl.com/58p584jp
Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD @JACCJournals @ksase @dineshpmcc1 @ICOSociety
Explore the benefits of cardiac MRI for your patients undergoing chemotherapy in this week's #CardioOnc webinar – ow.ly/ZX3350WltmL Chairs, Dr Dan Lenihan and Dr Joe Carver invite Dr Olga Toro-Salazar and Tiffany Berthod, RN for an educational discussion on: • Diagnostic…
Meet Adina Isenberg – a #cancer survivor, patient #advocate, and faculty at @harvardmed. Adina recounts her journey with breast cancer treatment and how it drove her to make a meaningful difference in countless lives. 🎧 Tune in: tinyurl.com/3hxw4kx8
A must read for oncologists - many of our pts are on QT prolonging medications; drug-drug interactions important to consider. @ICOSociety @CancerCareMASCC @ASCOPost